Direct to Patient Team Lead

How will your role help us transform hope into reality?

The Direct-to-Patient (DTP) Team Lead will be responsible for further establishing and maintaining a leadership position for Blueprint Medicines, a Sanofi Company, among the patient and caregiver community living with systemic mastocytosis (SM). Your strategic vision will ensure we have an wholistic patient and caregiver engagement strategies, including groundbreaking patient marketing strategies and initiatives for SM and AYVAKIT (avapritinib), a potential multi-billion opportunity. Working collaboratively with cross-functional partners, you will represent the Voice of the Patient and be the driving force behind patient engagement strategies that not only speak to patients but also reinforces our Patient First mindset.

AYVAKIT's ongoing launch into Indolent Systemic Mastocytosis (ISM), provides a unique opportunity to continue to build a new market and reach a patient community that had no therapeutic option until now that treated the underlying driver of disease. While ISM is a rare disease, it is extremely underdiagnosed with 9 years average time to diagnosis after seeing several types of medical specialists.

You will lead the Patient Marketing team, which is collectively responsible for creating and implementing strategies across disease awareness and product promotion to support personal and non-personal / digital promotion for patient audiences. You will be a leader in both the marketing team and broader patient connect team across the organization. Working closely with cross-functional partners : Patient Advocacy, PR / Corp Communications, Regional Marketing, Commercial Operations, and US Market Access / Patient Services is crucial to brand success. Your collaborative efforts will ensure a cohesive and patient-centric approach across all patient touchpoints.

This role will report to the US Brand Lead.

What will you do?

• Lead the US AYVAKIT patient marketing team, develop an industry-leading DTP team who are enthusiastic about patient marketing. Your strategic guidance and mentorship will empower them to deliver impactful campaigns and initiatives.
• Provide leadership to Blueprint Medicines and brand team to enable development, alignment and execution of patient strategy across the organization
• Spearhead cross-functional collaboration and alignment to ensure patient strategies are integrated across Blueprint Medicines, including leading broader patient connect team across organization
• Collect actionable patient insights that help understand the SM landscape, identify the emergent needs of SM patients and caregivers, guiding and encouraging understanding of insights cross functionally
• Guide the development and execution of core patient-facing initiatives, including the disease awareness campaign, AYVAKIT campaign updates, digital / print media, conferences, and non-personal tactics
• Provide strategic oversight for the Patient Ambassador Program (unbranded and branded), including programming strategy, goals and KPIs
• Lead digital marketing capability evolution (in collaboration with commercial operations) to ensure team can execute on multichannel promotion campaigns
• Accountable to patient-focused brand plan, proposing programs and capabilities needed to support the strategy and championing that plan through engagement with cross-functional partners
• Collaborate with legal, regulatory, and compliance stakeholders to ensure compliant development and execution of educational programming
• Required travel : Up to 25%
• Perform other responsibilities as assigned.

What minimum qualifications do we require?

What additional qualifications will make you a stronger candidate?

Why Blueprint?

At Blueprint Medicines, patients are our purpose. Their needs ignite our innovation, fuel our urgency and inspire us to go further - faster. We bet on bold people who want to grow, push boundaries and lead meaningful change. Here, you'll do the most impactful work of your career - because our commitment to changing lives isn't just what we do, it's who we are.

Patients are waiting. Are you ready to make the leap?

Compensation and Benefits

The base salary hiring range for this position will be $220,000 $ 275,000.

This position is also eligible for the following :

To apply, just scroll down and click on the "Apply Now" link.

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster an environment of fair treatment and full participation for all of our employees as we navigate complex challenges in pursuing our mission to improve the lives of patients. We celebrate our unique differences and varied career and life experiences so that we can sustain our diverse culture and ensure everyone feels accepted. We are committed to non-discrimination, equal employment opportunity, as well as an inclusive recruitment process. We consider all qualified applicants based on merit and without regard to race, color, sex, gender identity, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable federal or state law.

We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com. We are also an E-Verify Employer. For more information, please see our EEO Policy Statement, the E-Verify Participation Poster, the Right to Work Poster, and the EEO Know Your Rights Poster.

Blueprint Medicines, a Sanofi company, is a global biopharmaceutical company that invents life-changing medicines. We seek to improve and extend patients' lives by solving important medical problems, with a focus on allergy / inflammation and oncology / hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a track record of success with two approved medicines, including AYVAKIT / AYVAKYT (avapritinib) which we are bringing to patients with SM in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases and solid tumors. For more information, visit www.BlueprintMedicines.com and follow us on X (formerly Twitter; @BlueprintMeds) and LinkedIn.